Daiwa Securities Group Inc. - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 129 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$01380.0%0.00%
Q2 2023$0
-100.0%
1380.0%0.00%
Q1 2023$11380.0%0.00%
Q4 2022$0
-100.0%
1380.0%0.00%
Q3 2022$1,0000.0%1380.0%0.00%
Q2 2022$1,0000.0%1380.0%0.00%
Q1 2022$1,0000.0%1380.0%0.00%
Q4 2021$1,0000.0%1380.0%0.00%
Q3 2021$1,0000.0%1380.0%0.00%
Q2 2021$1,0000.0%1380.0%0.00%
Q1 2021$1,000
-50.0%
1380.0%0.00%
Q4 2020$2,000
-66.7%
138
-66.9%
0.00%
Q3 2020$6,000
-14.3%
417
+17.8%
0.00%
Q2 2020$7,0000.0%3540.0%0.00%
Q1 2020$7,0000.0%3540.0%0.00%
Q4 2019$7,000
+75.0%
354
-7.6%
0.00%
Q3 2019$4,000
+100.0%
3830.0%0.00%
Q2 2019$2,0000.0%383
+46.7%
0.00%
Q1 2019$2,0000.0%2610.0%0.00%
Q4 2018$2,000
-50.0%
2610.0%0.00%
Q3 2018$4,0000.0%2610.0%0.00%
Q2 2018$4,0000.0%2610.0%0.00%
Q1 2018$4,0002610.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$35,031,00023.03%
Palo Alto Investors LP 5,267,652$81,543,0004.28%
Fairmount Funds Management LLC 702,351$10,872,0003.89%
Birchview Capital, LP 188,000$2,910,0001.68%
Mesirow Financial Investment Management, Inc. 22,303$345,250,0001.09%
EMERALD ADVISERS, LLC 1,822,781$28,217,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 1,661,236$25,716,0000.90%
RICE HALL JAMES & ASSOCIATES, LLC 1,552,504$24,033,0000.85%
Altium Capital Management LP 133,951$2,074,0000.77%
Hood River Capital Management LLC 931,754$14,424,0000.48%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders